Now you can protect your family and friends from heart attacks as a study reveals that noninvasive CT angiography and stress tests can help predicting it.
The study appeared online in the journal Radiology.
According to researchers, a combination of invasive coronary angiography (ICA) and stress tests with single photon emission tomography (SPECT) myocardial imaging has been the gold standard for making these determinations, with ICA showing the blockages and SPECT the perfusion, or penetration of the blood into the tissue.
"Previous studies show that a lesion is hemodynamically significant if there is a significant blood pressure drop corresponding to a big reduction in blood flow across the stenosis," said study author Joao A.C. Lima.
"If plaque has those characteristics, the patient should be targeted for intervention, be it with a stent or downstream bypass surgery."
The researchers set out to determine if combined CT angiography (CTA) and CT myocardial stress perfusion imaging (CTP) could demonstrate similar or superior ability to ICA/SPECT in predicting future adverse events.
"Invasive angiography is generally safe, but it can cause vascular problems in a significant number of patients, most commonly at site of the puncture," Lima said.
"Now with just one noninvasive test we can get two important but different pieces of information about the coronary arteries," said co-author Marcus Chen.
They compared the invasive and noninvasive approaches on 379 patients, who were referred for ICA, from November 2009 to July 2011.
The researchers looked at the ability of both techniques to predict whether or not a future major adverse cardiac event (MACE)- such as a heart attack,
revascularisation, arrhythmia or hospitalisation for chest pain or congestive heart failure- would occur.
The results indicated that 51 patients experienced one or more major adverse cardiac events, including 49 revascularisations, five myocardial infarctions - a heart attack, one cardiac death, nine hospitalisations for chest pain or congestive heart failure and one arrhythmia - a condition in which the heart beats with an irregular or abnormal rhythm.
"The noninvasive option should be a preferred or at least strongly considered option by cardiologists and radiologists managing these patients because it is safer and less expensive, and patients like it better," Chen stated.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
